A novel and efficient nicotine vaccine using nano-lipoplex as a delivery vehicle

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 1, 2014, Pages 64-72

  Hu, Yun ^a   Zheng, Hong ^a   Huang, Wei ^a   Zhang, Chenming ^a  

^a Virginia Polytechnic Institute and State University   (United States)

Author keywords

Active immunization; Antigen delivery; Lipoplex nanoparticle; Nanovaccine; Nicotine; Nicotine vaccine

Indexed keywords

ALUMINUM POTASSIUM SULFATE; BOVINE SERUM ALBUMIN; CATION; DRUG ANTIBODY; LIPOPLEX; LIPOSOME; NANOPARTICLE; NICOTINE VACCINE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; IMMUNOGENICITY; IMMUNOSTIMULATION; MOLECULAR SIZE; MOUSE; NANOPHARMACEUTICS; NONHUMAN; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84896725540     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.26635     Document Type: Article

References (32)

1. Mackay J. The global epidemiology of tobacco and related chronic diseases. Public Health 2012; 126:199-201; PMID:22326602; http://dx.doi.org/10. 1016/j.puhe.2012.01.027
2. Messer K, Trinidad DR, Al-Delaimy WK, Pierce JP. Smoking cessation rates in the United States: a comparison of young adult and older smokers. Am J Public Health 2008; 98:317-22; PMID:18172143; http://dx.doi.org/10.2105/AJPH.2007. 112060
3. de Villiers SH, Lindblom N, Kalayanov G, Gordon S, Baraznenok I, Malmerfelt A, Marcus MM, Johansson AM, Svensson TH. Nicotine hapten structure, antibody selectivity and effect relationships: results from a nicotine vaccine screening procedure. Vaccine 2010; 28:2161-8; PMID:20060511; http://dx.doi.org/10.1016/j.vaccine.2009.12.051
4. Fahim RE, Kessler PD, Fuller SA, Kalnik MW. Nicotine vaccines. CNS Neurol Disord Drug Targets 2011; 10:905-15; PMID:22229310; http://dx.doi.org/10.2174/ 187152711799219343
5. Sanderson SD, Cheruku SR, Padmanilayam MP, Vennerstrom JL, Thiele GM, Palmatier MI, Bevins RA. Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant. Int Immunopharmacol 2003; 3:137-46; PMID:12538044; http://dx.doi.org/10.1016/ S1567-5769(02)00260-6
6. Lisy K. Nicotine vaccines for smoking cessation. Clin Nurse Spec 2013; 27:71-2; PMID:23392063; http://dx.doi.org/10.1097/NUR.0b013e31828191a3
7. Raupach T, Hoogsteder PH, Onno van Schayck CP. Nicotine vaccines to assist with smoking cessation: current status of research. Drugs 2012; 72:e1-16; PMID:22356293; http://dx.doi.org/10.2165/11599900-000000000-00000
8. Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 2008; 38:1404-13; PMID:18389478; http://dx.doi.org/10.1002/ eji.200737984
9. Lopez-Marin LM, Tamariz E, Acosta-Torres LS, Castaño VM. Therapeutic proteins and nanotechnology: immune response and stealth bioengineered constructs. Curr Drug Metab 2013; 14:531-9; PMID:23687924; http://dx.doi.org/10.2174/13892002113149990006
10. Zhuang Y, Ma Y, Wang C, Hai L, Yan C, Zhang Y, Liu F, Cai L. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution. J Control Release 2012; 159:135-42; PMID:22226776; http://dx.doi.org/10.1016/j.jconrel.2011.12.017
11. Alving CR. Liposomes as carriers of antigens and adjuvants. J Immunol Methods 1991; 140:1-13; PMID:1712030; http://dx.doi.org/10.1016/0022-1759(91) 90120-5
12. Wieber A, Selzer T, Kreuter J. Physico-chemical characterisation of cationic DOTAP liposomes as drug delivery system for a hydrophilic decapeptide before and after freeze-drying. Eur J Pharm Biopharm 2012; 80:358-67; PMID:22119734; http://dx.doi.org/10.1016/j.ejpb.2011.11.008
13. Henriksen-Lacey M, Christensen D, Bramwell VW, Lindenstrøm T, Agger EM, Andersen P, Perrie Y. Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. J Control Release 2010; 145:102-8; PMID:20381556; http://dx.doi.org/10.1016/j.jconrel. 2010.03.027
14. Huang W, Zhang C. Assembly and characterization of lipid-lipid binding protein particles. J Biotechnol 2011; 154:60-7; PMID:21540063; http://dx.doi.org/10.1016/j.jbiotec.2011.04.006
15. Pravetoni M, Keyler DE, Pidaparthi RR, Carroll FI, Runyon SP, Murtaugh MP, Earley CA, Pentel PR. Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities. Biochem Pharmacol 2012; 83:543-50; PMID:22100986; http://dx.doi.org/10.1016/j.bcp.2011.11.004
16. Langone JJ, Gjika HB, Van Vunakis H. Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine. Biochemistry 1973; 12:5025-30; PMID:4761980; http://dx.doi.org/10.1021/bi00748a032
17. Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 2012; 41:2971-3010; PMID:22388185; http://dx.doi.org/10.1039/c2cs15344k
18. Moreno AY, Azar MR, Warren NA, Dickerson TJ, Koob GF, Janda KD. A critical evaluation of a nicotine vaccine within a self-administration behavioral model. Mol Pharm 2010; 7:431-41; PMID:20104903; http://dx.doi.org/10. 1021/mp900213u
19. Polosa R, Benowitz NL. Treatment of nicotine addiction: present therapeutic options and pipeline developments. Trends Pharmacol Sci 2011; 32:281-9; PMID:21256603; http://dx.doi.org/10.1016/j.tips.2010.12.008
20. Hoffmann-Röder A, Johannes M. Synthesis of a MUC1-glycopeptide-BSA conjugate vaccine bearing the 3′-deoxy-3′-fluoro-Thomsen- Friedenreich antigen. Chem Commun (Camb) 2011; 47:9903-5; PMID:21818465; http://dx.doi.org/10.1039/c1cc13184b
21. Kubler-Kielb J, Majadly F, Biesova Z, Mocca CP, Guo C, Nussenzweig R, Nussenzweig V, Mishra S, Wu Y, Miller LH, et al. A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates. Proc Natl Acad Sci U S A 2010; 107:1172-7; PMID:20080619; http://dx.doi.org/10.1073/ pnas.0913374107
22. Henriksen-Lacey M, Christensen D, Bramwell VW, Lindenstrøm T, Agger EM, Andersen P, Perrie Y. Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N′,N′-Dimethylaminoethane) carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses. Mol Pharm 2011; 8:153-61; PMID:21117621; http://dx.doi.org/10.1021/mp100208f
23. Khalil IA, Kogure K, Akita H, Harashima H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev 2006; 58:32-45; PMID:16507881; http://dx.doi.org/10.1124/pr.58.1.8
24. Vangasseri DP, Cui Z, Chen W, Hokey DA, Falo LD Jr., Huang L. Immunostimulation of dendritic cells by cationic liposomes. Mol Membr Biol 2006; 23:385-95; PMID:17060156; http://dx.doi.org/10.1080/09687860600790537
25. Carstens MG, Camps MG, Henriksen-Lacey M, Franken K, Ottenhoff TH, Perrie Y, Bouwstra JA, Ossendorp F, Jiskoot W. Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines. Vaccine 2011; 29:4761-70; PMID:21565240; http://dx.doi.org/10.1016/j.vaccine.2011.04.081
26. Keyler DE, Roiko SA, Earley CA, Murtaugh MP, Pentel PR. Enhanced immunogenicity of a bivalent nicotine vaccine. Int Immunopharmacol 2008; 8:1589-94; PMID:18656557; http://dx.doi.org/10.1016/j.intimp.2008.07.001
27. Baylor NW, Egan W, Richman P. Aluminum salts in vaccines - US perspective. Vaccine 2002; 20(Suppl 3):S18-23; PMID:12184360; http://dx.doi.org/10.1016/S0264-410X(02)00166-4
28. Huang W, Zhang J, Dorn HC, Geohegan D, Zhang C. Assembly of single-walled carbon nanohorn supported liposome particles. Bioconjug Chem 2011; 22:1012-6; PMID:21528932; http://dx.doi.org/10.1021/bc200098k
29. Singh KV, Kaur J, Varshney GC, Raje M, Suri CR. Synthesis and characterization of haptenprotein conjugates for antibody production against small molecules. Bioconjug Chem 2004; 15:168-73; PMID:14733597; http://dx.doi.org/10.1021/bc034158v
30. Ansell SM, Tardi PG, Buchkowsky SS. 3-(2-pyridyldithio)propionic acid hydrazide as a cross-linker in the formation of liposome-antibody conjugates. Bioconjug Chem 1996; 7:490-6; PMID:8853463; http://dx.doi.org/10.1021/bc960036+
31. Ansell SM, Harasym TO, Tardi PG, Buchkowsky SS, Bally MB, Cullis PR. Antibody conjugation methods for active targeting of liposomes. Methods Mol Med 2000; 25:51-68; PMID:21318840
32. Kaszuba M, Corbett J, Watson FM, Jones A. High-concentration zeta potential measurements using light-scattering techniques. Philos Trans A Math Phys Eng Sci 2010; 368:4439-51; PMID:20732896; http://dx.doi.org/10.1098/rsta. 2010.0175